See more : Sisram Medical Ltd (1696.HK) Income Statement Analysis – Financial Results
Complete financial analysis of MARX Biotech Co., Ltd. (7731.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MARX Biotech Co., Ltd., a leading company in the None industry within the None sector.
You may be interested
- Purmo Group Oyj (PURMO.HE) Income Statement Analysis – Financial Results
- Iberpapel Gestión, S.A. (IBG.MC) Income Statement Analysis – Financial Results
- Essex Bio-Technology Limited (1061.HK) Income Statement Analysis – Financial Results
- Johnson Service Group PLC (JSG.L) Income Statement Analysis – Financial Results
- Thanachart Capital Public Company Limited (NFPH.F) Income Statement Analysis – Financial Results
MARX Biotech Co., Ltd. (7731.TWO)
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 289.93M | 110.64M | 97.61M | 0.00 |
| Cost of Revenue | 75.33M | 26.43M | 22.82M | 0.00 |
| Gross Profit | 214.59M | 84.21M | 74.79M | 0.00 |
| Gross Profit Ratio | 74.02% | 76.11% | 76.63% | 0.00% |
| Research & Development | 597.00K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 27.77M | 12.27M | 9.00M | 0.00 |
| Selling & Marketing | 200.56M | 70.05M | 48.91M | 0.00 |
| SG&A | 228.33M | 82.32M | 57.91M | 0.00 |
| Other Expenses | -14.34M | 4.09M | 2.63M | 0.00 |
| Operating Expenses | 214.59M | 82.32M | 57.91M | 0.00 |
| Cost & Expenses | 289.93M | 108.75M | 80.72M | 0.00 |
| Interest Income | 530.00K | 37.00K | 7.00K | 0.00 |
| Interest Expense | 372.00K | 114.00K | 49.00K | 0.00 |
| Depreciation & Amortization | 4.59M | 1.95M | 1.32M | 0.00 |
| EBITDA | -10.52M | 6.97M | 19.01M | 0.00 |
| EBITDA Ratio | -3.63% | 7.20% | 21.35% | 0.00% |
| Operating Income | -14.34M | 6.01M | 19.53M | 0.00 |
| Operating Income Ratio | -4.94% | 5.44% | 20.01% | 0.00% |
| Total Other Income/Expenses | -1.15M | 3.01M | 759.00K | 0.00 |
| Income Before Tax | -15.49M | 4.91M | 17.65M | 0.00 |
| Income Before Tax Ratio | -5.34% | 4.43% | 18.08% | 0.00% |
| Income Tax Expense | -2.57M | 2.08M | 3.87M | 0.00 |
| Net Income | -12.92M | 2.83M | 13.78M | 0.00 |
| Net Income Ratio | -4.46% | 2.56% | 14.12% | 0.00% |
| EPS | -0.07 | 0.02 | 0.10 | 0.00 |
| EPS Diluted | -0.07 | 0.02 | 0.10 | 0.00 |
| Weighted Avg Shares Out | 172.93M | 172.93M | 137.78M | 212.37M |
| Weighted Avg Shares Out (Dil) | 174.22M | 174.22M | 137.78M | 212.37M |
No news found for: 7731.TWO
Source: https://incomestatements.info
Category: Stock Reports